瀛晟科學(00209.HK)擬配售3095.15萬股 總籌1083.3萬港元
格隆匯9月11日丨瀛晟科學(00209.HK)公告,於2025年9月11日,公司與配售代理訂立配售協議,據此,配售代理同意按悉數包銷基準按每股配售股份0.350港元之價格爲及代表公司向不少於六名承配人配售3095.15萬股新股份。配售股份將根據一般授權配發及發行。配售價每股配售股份0.350港元較:(i)於配售協議日期在聯交所所報之收市價每股股份0.345港元溢價約1.45%;及(ii)於緊接配售協議日期前五個連續交易日在聯交所所報每股股份之平均收市價0.377港元折讓約7.16%。假設於本公告日期與配售事項完成之間,公司已發行股本將不會發生變動,配售事項項下之3095.15萬股新股份佔於本公告日期公司現有已發行股份總數的20%,及佔經配售事項擴大後公司已發行股份總數約16.67%。配售股份之總面值將爲30.95萬港元。配售事項之所得款項總額將爲1083.3萬港元。經扣除所有相關開支後,配售事項之所得款項淨額估計約爲1032萬港元,其(i)約50%擬用作償還貸款,及(ii)約50%擬用作本集團營運資金及一般企業用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.